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Abstract 
This study is a longitudinal experimental design that examine the 
effects of aromatherapy on sleep quality in diabetes patients with restless leg 
syndrome (RLS). Patients in the experimental group received the 
aromatherapy intervention for 6 weeks, while those in the control group 
received only regular nursing care. The instruments included Pittsburg Sleep 
Quality Index and SureStep TM of blood glucose meters. Data were collected 
at pre-test, 2nd week, 4th week, and 6th week after the aromatherapy. Data 
analysis included descriptive analysis, chi-square, independent t test, Pearson 
correlation, repeated measure ANOVA and general linear mixed-effect 
models. Forty-four diabetes patients with RLS were randomly assigned to the 
experimental group (n=22) and the control group (n=22) at a hospital in 
northern Taiwan. Sleep quality of diabetes patients with RLS was poor in this 
study. Sleep latency of patients in the experimental group was improved at 
2nd week after aromatherapy. Subjective sleep quality and sleep disturbance 
of patients was also improved at 4th week after aromatherapy. At 6th week, 
patients in the experimental group had increased their sleep duration, and 
improved their overall sleep quality. The level of blood sugar was decreased 
at 2nd week after aromatherapy on experimental group. Based on the analysis 
it was concluded that Aromatherapy can ameliorate both blood sugar and 
sleep quality of diabetes patients with RLS. Thus aromatherapy can be a safe, 
noninvasive, effective approach for clinical nurses as a therapy in routine care 
to improve sleep quality in diabetes patients with neuropathy. 
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Introduction 
Sleep disorders are becoming more prevalent, affecting physical and 
mental health and are considered to be an important part of overall health in 
our modern society. Sleep disorders may be caused by various medical 
conditions, mental illnesses and chronic diseases such as diabetes and heart 
disease. (Talih, Ajaltouni, & Kobeissy, 2016). Sleep Medicine is experiencing 
an increase in the demand for knowledge, and is a common clinical problem 
encountered in psychiatry and clinical practice. Diagnosis of insomnia is 20%, 
8% of sleep apnea, and 18% of restless leg syndrome (RLS) (Adams, 
Appleton, Taylor, McEvoy, & Antic, 2016). Patients with sleep disorders have 
also complained about dissatisfaction with sleep quality, sleep time and the 
amount of sleep received. 
Sleep disorders are often one of the common problems in people with 
diabetes. Diabetic patients most often suffer from difficulty falling asleep. 
Diabetes associated with sleep disorders is a life-threatening disease with 
increasing prevalence. RLS is also a common occurrence, more than 50% of 
patients with diabetes with restless leg syndrome have poor sleep quality. RLS 
is the main cause of impaired sleep quality and quantity. (Mallon, Broman, & 
Hetta, 2005; Modarresnia, Golgiri, Madani, Emami, & Tanha, 2018). It not 
only has a major impact on sleep quality and quality of life, but also poses a 
significant burden on health and health-related costs (Allen, Bharmal, & 
Calloway, 2011). 
Aromatherapy is the use of pure essential oils from aromatic plants to 
help alleviate health problems and improve quality of life. Lavender is 
traditionally used for oral administration, it is also being employed in 
aromatherapy with inhalation, a, massage, dripping oil (rub on the pillow), and 
bathing. Lavender oil is undiluted to the skin which unlike many other 
essential oils used in aromatherapy (Koulivand, Ghadiri, and Gorji, 2013). 
Lavender oil is the most complete oil in terms of relaxation, with evidence 
based from fictional science (de Sousa, Almedia, Andrade, & Andreatin, 
2015). Lavender is used for stress, anxiety, fatigue, headache, migraine, 
insomnia and depression (Katona, Sovilj, and Petrovi, 2010). According to a 
study, it is found that lavender essential oil aromatherapy calms the nervous 
system - lowering blood pressure, heart rate and skin temperature, and allows 
brain wave changes to a more relaxed state (Sayorwan, et al., 2012). Lewith, 
Godfrey and Prescott (2005) used a 1% lavender essential oil to measure the 
sleep quality of adults with mild insomnia. Another study on aromatherapy for 
ICU patients with severe coronary heart disease, results have shown that, 
patients receiving aromatherapy have improved sleep quality (Karadag, 
Samancioglu, Ozden, and Bakir, 2015). A study pointed to the influence of 
lavender aromatherapy on sleep quality and vital signs in hospitalized patients, 
showing significant differences in sleep quality and nocturnal blood pressure 
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control (Lytle, Mwatha, & Davis, 2014). Up until now, although nursing 
interventions have been effective in terms of sleep quality, there is still lack of 
high evidence strength results. Further research is carried out, there will 
certainly be a significant change in clinical practice.  
With regards to resolving patients with sleep disorders, apart from 
giving patient sedatives and sleeping drugs to help improve sleep disorders, 
nursing staff should also try various methods to help promote sleep and assists 
in providing safe, non-invasive sleep improvement measures. Therefore, the 
effects of aromatherapy on sleep improvement are what nurses are striving 
towards.  
 
Research Question 
Is aromatherapy effective in improving sleep quality and blood glucose 
levels in patients with diabetes and RLS? 
 
Conceptual framework 
This study investigated the sleep quality of patients in diabetes with 
RLS, on whether intervention of aromatherapy measures will improve sleep 
problems and blood glucose level. In the experimental group, besides the 
researchers providing lavender essential oils, regular telephonic calls to the 
patient was made to assess the patients’ use of essential oils and sleep 
conditions; the control group received general sleep hygiene education and 
telephonic calls to patients about their sleep conditions. The conceptual 
architecture of this study is shown below in figure 1. 
 
Figure 1. Conceptrual famework 
 
Research Design 
This study is a longitudinal experimental design to explore the effects 
of aromatherapy intervention on sleep quality and blood glucose in patients of 
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diabetes with RLS. The independent variable was aromatherapy, and the 
dependent variables were sleep quality and blood glucose values. The subjects 
were divided into experimental group and control group, and a continuity 
study was carried out. The research design is shown in Table 1. 
Table 1: Research Design 
 Pretest Aromatherapy 1th  posttest 2nd posttest 3rd posttest 
experimental group O1 X O2 O3 O4 
control group O1  O2 O3 O4 
O1 (pretest): measure of basic information table, PSQI, and monitorblood glucose value 
before meal in the morning for 2days. 
X = aromatherapy intervention. 
O2 (1st posttest), O3 (2nd posttest), and O4 (3rd posttest): measure of PSQI, monitor blood 
glucose value before meal in the morning for 2days. 
 
Study population 
This study is based on diabetes patients with RLS in the outpatient 
department of metabolism, using the random allocation method. The samples 
were taken from 900 hospital beds in the regional hospital of northern Taiwan. 
The inclusion criterias were 1.from the outpatient department of metabolism, 
patients diagnosed with diabetes and RLS by a physician; 2. ages between 20-
65 years old; 3. consciousness and ability to express oneself; 4. no serious 
dysosmia; 5. currently not taking sleeping pills; 6. can communicate in 
Taiwanese and Mandarin, and after explanation, agreeing to participate in the 
research; and 7. PSQI assessment results > 5 points. The exclusion criterias 
were 1. asthmatic patients; 2.sleep apnoea and disruption; and 3. refusal to 
participate or disagree to participate. 
 
Sample size 
The estimated number of samples for this study was analyzed using the 
Mahmood (2004) statistical software (PASS 2000), which randomly assigned 
the order and results of random assignments that control the different attributes 
of the parallel group experiments. The estimation method of this study is based 
on the prediction of the main independent variable sleep efficiency, setting 
alpha value at 0.05, power as 0.8 and effect size as 0.4 as estimation.  It is 
estimated that in a single group, at least 22 patients are present, samples were 
representative, and the data were collected according to the patients who met 
the selection criteria.  
A total of 65 patients with diabetes with RLS were screened during the 
study period. 
17 patients using the PSI achieved a score of ≦5 points did not meet the 
criteria. The number of patients who met the conditions for admission was 48 
patients, including 23 patients in the experimental group and 25 patients in the 
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control group. After one week of tracking in the experimental group, one 
patient had to travel to other countries for 3 months, and voluntarily gave up 
participating in the study. Three people in the control group did not complete 
the research follow-up. Finally, there were 44 patients who were completely 
tracked for a 6 week period, of those, 22 patients from the experimental group, 
and 22 patients in the control group. 
 
Study protocol 
This study used a double blinding design as approach. Prior to the 
study being carried out, a researcher assistant was first trained, to ensure there 
was consistency in filling out of the front and back pages of questionnaires 
when data collection was taken. From the outpatient department of 
metabolism, the physician referred patients with diabetes with RLS to a 
researcher, from which the researcher screened the patients who met the 
conditions of the cases. Firstly, the researcher assistant asked each patient to 
explain the purpose and process of the study, and the patients or family signed 
the consent forms. The patients were divided into experimental group and 
control group by random allocation, performed by Random Allocation 
Software's Random Block Size. The patients were assigned to the 
experimental group or the control group in sequence. Both the patient and the 
researcher are unknown as the experimental group and the control group. The 
two groups filled out the patient basic information table, the PSQI Scale, and 
monitored the morning blood glucose level for 2 days on the first day of the 
case. In the second, fourth and sixth weeks, the PSQI and before breakfast 
blood glucose level were measured for 2 days to understand the effect of 
aromatherapy on sleep improvement in patients of diabetes with RLS. The 
experimental group was used with aromatherapy, which was, a bottle of 
lavender essential oil was given after the case was received, and a drop of oil 
both left and right was placed on the pillow every night, before going to bed; 
the control group did not receive any intervention measures for a total of 6 
weeks. During the study period, the researcher assistant called the patient's 
home every 5 days to remind them, and to track them on the progress. After 
the study, the lavender essential oil was given to the patient. The patient in the 
control group was also called by the researcher every 5 days, caring about their 
sleep situation, in order to avoid any deviation from the experimental group. 
After the study, the clinical outcomes of aromatherapy were reported to the 
two groups. 
 
Instrument 
           The PSQI was developed in 1989 by Buysse, et.al, with reference to 
relevant literature and contents of the previous sleep quality questionnaire. 
The scale was developed to test the sleep quality of clinical patients. This scale 
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is a measure of the patient's sleep over the past month. Most of the time frame 
records the nightly sleep situation. In general, clinically, the time frame 
between the past 1-2 weeks is asked to distinguish between sporadic and 
persistent insomnia. The total score was calculated by its development scoring 
method, and the score ranged from 0 to 21 points. The higher the score, the 
worse the sleep quality, and the total score of greater than 5 points indicated 
that there was sleep disorder. The PSQI distinguishes between sleep problems, 
difficulty falling asleep, or excessive drowsiness with an accuracy of 88.5%. 
The sensitivity was 89.6% and the specificity was 86.5%. In terms of 
reliability, the Cronbach's α of the original scale was 0.83 (Buysse, Reynolds, 
Monk, Berman & Kupfer, 1991). This study is based on the Mandarin PSQI 
by Wang (2004), which is used to obtain the consent of the original scale 
developer Dr. Buysse. The CVI was 0.94, changed the measurement time of 
the scale to one week for consistency. According the study by Lei (2003) 
changed the measurement time of the scale to two weeks. Our study is to 
confirm the effect and effective period of the aromatherapy of lavender 
essential oil, taking into consideration that it may take some time to assess the 
effective improvement of the overall sleep quality. In terms of the validity of 
the scale, this scale has a total score for comparative diagnosis, which can 
clearly distinguish the quality of sleep. In this study, the PSQI had a cronbach's 
α of 0.78. The blood glucose monitor is an essential monitoring tool for 
diabetic patients. The patient takes the blood glucose reading at home. This 
research laboratory uses a simple blood glucose test machine of the same 
brand, which is executed by the patient at home, and is corrected once after 
each use. 
 
Data analysis 
After investigating the questionnaire data obtained by the researchers. 
The statistical method were used with percentage, Chi Square and ANOVA. 
The significance level was set to p<0.05. In this study, sleep latency, 
individual subjective sleep quality, daytime dysfunction, sleep disturbance, 
and blood glucose values were corrected for the interaction between 
repeatedly measured variables using a generalized liner mixed-effects model  
(Mixed effects GLMs). The statistical strength of subsequent measurements 
was corrected to accurately assess the important effects of aromatherapy on 
and between groups, and within the group under relevant factors that control 
repeated observations of the same patient. 
 
Result 
Demographic information 
The average age of the experimental group was 52.82±7.532 and the 
control group was 51.68±8.812, of which were mostly female (61.3%) and 
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married (93.2%). There were 52.3% high schools of education levels; 
occupation distribution was equal- half had jobs and of the other half were 
jobless; most of the participants were non-smokers (81.8%) and non-drinkers 
(90.9%); tea (79.5%) and coffee (86.4%) were mostly not consumed or 
occasionally consumed; most participants did not suffer from depression 
(75%); there were 65.9% patients with  BMI>25; nocturia (59.1% ) were  
between the two groups; most participants did not exercise regularly (59.1%). 
According to the analysis results of Chi-square test and Independent t test, 
there was no statistically significant difference between the experimental 
group and the control group based on the comparison of basic data (P>0.05). 
The homogeneity of the group is high. 
With the seven domains of the PSQI, Table 2 shows the results of the 
pre-test, the patients in the experimental group and the control group were 
consistent with the worst of the first three items in the PSQI and its subscale, 
before aromatherapy intervention was introduced. In pretest, the physiological 
blood glucose level, the average score of the experimental group and the 
control group were no statistically significant difference between the two 
groups. 
Table 2. Diabetes with RLS Pre-measurement of Pittsburgh Scale Comparison of Sleep 
Quality Distribution and Blood Glucose Value 
  experimental group Control group 
T p 
 Mean±SD Mean±SD 
Subjective sleep quality  2.09±0.75 1.77±0.69 1.47 0.15 
sleep latency 2.41±0.73 2.05±0.79 1.59 0.12 
sleep duration 1.73±0.88 1.09±0.92 2.34 0.02* 
sleep efficiency 1.23±1.19 0.55±0.67 2.34 0.02* 
sleep disturbance 1.55±0.60 1.32±0.57 1.30 0.20 
daytime dysfunction 1.82±0.59 1.68±0.89 0.60 0.55 
overall sleep quality 10.59±2.15 8.64±2.22 2.54 0.02* 
Blood sugar 186.23±61.75 168.27±55.47 1.02 0.32 
P<0.05*; p<0.01** 
 
Results of Aromatherapy intervention in two groups on sleep quality 
Differences between the two groups in aromatherapy intervention for 
sleep latency, subjective sleep quality, sleep disturbance, and daytime 
dysfunction 
Table 2 shows that the patients in the experimental group and the 
control group were tested by independent t test in terms of subjective sleep 
quality, sleep latency, sleep disturbance, daytime dysfunction and blood 
glucose level. According to the independent t test, there was no statistically 
significant difference, indicating that the two groups were highly 
homogenous. Table 3 shows the subjective sleep quality, sleep latency, sleep 
disturbance, and daytime dysfunction of the two groups of patients in the pre-
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test, the first post-test, the second post-test, and the third post-test. The 
interaction was detected by ANOVA. Daytime dysfunction had no interaction 
(p>0.05), and the remaining variables showed interaction (p<0.05). Therefore, 
the general linear mixed-effect model (GLMM) analysis was used, and the 
interaction between the repeated measures of the variables was corrected to 
detect the difference between the two groups of patients after the aromatherapy 
intervention; according to table 2, there were statistically significant 
differences in sleep hours, sleep efficiency, and overall sleep quality between 
the two groups (P<0.05).  
 
Differences in time-dependent changes between two groups of 
aromatherapy intervention on sleep latency 
Differences in time-dependent changes between two groups of 
aromatherapy intervention on sleep latency. The difference between the pre- 
and post-test was measured by paired-sample t test. The changes in sleep 
latency of the two groups before and after aromatherapy intervention are 
shown in Figure 3, showing the trend of sleep latency. With observation and 
time tracking, there was a specific interaction between group and time (table 
3).After 4 weeks of intervention, the effect β value of sleep latency was 0.59 
(p<0.05), the effect β value was -0.50 (p=0.05) after 4 weeks of intervention. 
After 6 weeks, the effect of β value was -0.64 (p=0.01) (table 4). The 
intervention of aromatherapy, the experimental group showed significant 
differences in the sleep latency at the second week in comparison with the 
control group, and continued until the sixth week. 
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Table 3. Results of Aromatherapy intervention in two groups on sleep quality 
 
experimental group (mean±SD)  Control group (mean±SD) 
α p 
Pre-test 1st post-test  2nd post-test  3rd post-test  Pre-test 1st post-test  2nd post-test  3rd post-test  
sleep latency 2.41±0.73 1.82±0.78 1.86±0.89 1.77±0.87 2.05±0.79 1.91±0.87 2.00±0.69 2.05±0.72 7.16 0.01** 
subjective sleep 
quality 
2.09±0.75 1.41±0.59 1.28±0.53 1.27±0.46 1.77±0.69 1.36±0.73 1.41±0.73 1.59±0.67 8.99 0.01** 
daytime 
dysfunction 
1.82±0.59 1.68±0.84 1.41±0.59 1.41±0.50 1.68±0.89 1.50±0.67 1.46±0.74 1.55±0.74 1.98 0.17 
sleep disturbances 1.55±0.60 1.18±0.59 1.14±0.56 1.09±0.43 1.32±0.57 1.27±0.55 1.27±0.55 1.27±0.55 7.07 0.01** 
Blood sugar 186.22±61.75 145.00±47.04 149.00±42.48 149.18±51.55 168.27±55.46 166.22±41.34 170.36±46.00 157.22±47.36 3.32 0.05* 
P<0.05*; p<0.01**; 1st post-test indicates on 2 weeks after intervention; 2nd post-test indicates on 4 weeks after intervention; 3rd post-test 
indicates on 6 weeks after intervention. 
                        
 
Figure 3. Comparison of group                                   Figure 4. Comparison of group 
differences in sleep latency                                        differences in sleep quality 
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Table 4. Differences between the two groups in aromatherapy intervention for sleep latency, subjective sleep quality, improvement of sleep 
disturbance, and daytime dysfunction 
 
sleep latency subjective sleep quality daytime dysfunction sleep disturbances Blood sugar 
β S.E. p β S.E. p β S.E. p β S.E. p β S.E. p 
group                
（experimental group vs. 
control group） 
0.36 0.23 0.12 -0.32 0.22 0.42 0.14 0.23 0.55 0.28 0.18 0.20 17.95 17.70 0.32 
time                
    1st post-test vs. pre-test -0.14 0.17 0.44 -0.41 0.32 0.01* -0.18 0.17 0.29 -0.45 0.09 0.65 -2.05 8.85 0.83 
    2nd post-test vs. pre-test -0.05 0.17 0.79 -0.36 0.17 0.04* -0.23 0.17 0.20 -0.45 0.12 0.70   2.36 9.13 0.80 
    3rd post-test vs. pre-test 0.00 0.15 1.00 -0.18 0.14 0.21 -0.32 0.14 0.35 -0.45 0.10 0.65 -11.05 1.00 0.30 
group *time（experimental 
group vs. control group） 
               
    1st post-test vs. pre-test -0.59 0.24 0.03* 0.27 0.20 0.18    -0.32 0.13 0.07 -39.18 12.51 0.02* 
    2nd post-test vs. pre-test -0.50 0.24 0.05* -0.50 0.24 0.04*    -0.36 0.16 0.04* -39.59 12.91 0.02* 
    3rd post-test vs. pre-test -0.64 0.21 0.01* -0.64 0.20 0.00**    -0.41 0.13 0.02* -26.00 14.13 0.10 
P<0.05*; p<0.01**; 1st post-test indicates on 2 weeks after intervention; 2nd post-test indicates on 4 weeks after intervention; 3rd post-test 
indicates on 6 weeks after intervention. 
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Differences in time-dependent changes between two groups of 
aromatherapy intervention on subjective sleep quality 
Differences in time-dependent changes between two groups of 
aromatherapy intervention on subjective sleep quality. The subjective sleep 
quality of the two groups of patients before and after the intervention of 
aromatherapy is shown in Figure 4. In the experimental group, the subjective 
sleep quality of the first post-test was worse than that of the control group, and 
the estimated value β was 0.27 (p=0.18). With continuous observation and 
time tracking, the group and the time show a specific interaction (table 3). In 
the experimental group, the score of the second post-test was compared with 
that of the pre-test score, which fared better than that of the control group. The 
estimated value β was -0.50 (p=0.04). Patients in the third post-test group was 
still better than the control group, and the estimated value β was -0.64 (p=0.00) 
(table 4). Continued observation and follow-up time after aromatherapy 
intervention showed that the subjective sleep quality test group had significant 
differences compared with the control group during fourth and sixth week. 
 
Differences in time-dependent changes between two groups of 
aromatherapy intervention on sleep disturbances 
Differences in time-dependent changes between two groups of 
aromatherapy intervention on sleep disturbances. With continuous 
observation and time tracking, the group and time shows a specific interaction 
as seen in Figure 5. In the experimental group, although the sleep disturbance 
in the first post-test was better than that in the control group, the estimated 
value β was -0.32 (p=0.07). In the experimental group, the second post-test 
score and the third post-test score were significantly better than the pre-test 
score, which was better than the control group. The estimated value β was -
0.36 (p=0.04) and β-0.41 (p=0.02) (table 4). There are statistically significant 
differences. Observations with follow-up time after aromatherapy intervention 
showed that the sleep disturbances in the experimental group were 
significantly different from the control group at fourth and sixth week. 
 
Figure 5. Comparison of group differences in sleep disturbance 
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Differences in time-dependent changes between two groups of 
aromatherapy intervention on blood glucose values 
As seen in Figure 6, the pre-test blood glucose level in the experimental 
group was higher than that of the control group. The blood glucose level of 
the first post measurement of the experimental group was lower than that of 
the control group. The estimated value β was -39.18 (p =0.02). In the second 
post-measurement compared with the pre-measured value, the results fared 
slightly better than the control group, with the estimated value β at -39.59 
(p=0.02), showing a significant change. The third post-test was compared with 
the pre-test. The patients in the experimental group fared better than the 
patients in the control group. The estimated value β was -26.00 (p=0.10) (table 
4), which was not statistically significant. Observations with follow-up time 
after aromatherapy intervention showed that the blood glucose test group was 
significantly different from the control group at second and fourth week. 
 
Figure 6. Comparison of group differences in blood sugar 
 
Pre-test and post-test changes in patient group before and after 
comparing differences in sleep hours, sleep efficiency, and overall sleep 
quality 
The sleep quality of the experimental group was measured at two time 
points, pre-test and third post-test. The paired t test (Paired-sample t test) was 
used to analyze the sleep time t=2.41 (p<0.05), and the sleep efficiency t= 2.03 
(P>0.05), overall sleep quality t=7.26 (p=0.00). There was a statistically 
significant difference in sleep hours and overall sleep quality between the 
groups (P<0.05).  The control group measured at pre-test and third post- test 
showed that the sleep time was t=0.00 (p=1.00), the sleep efficiency was t=-
0.94 (p=0.36), and the overall sleep quality was t=2.10 (p=0.05). There was 
only a statistically significant difference in overall sleep quality between the 
groups (P<0.05) (Table 5). 
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Table 5. Differences in sleep hours, sleep efficiency, and overall sleep quality changes in 
the group 
 
Pretest 
Mean±SD 
3rd posttest 
Mean±SD 
Differences of 
Mean±SD 
t p 
experimental 
group 
sleep duration 1.73±0.88 1.32±1.00 -0.41±0.75 2.41 0.03* 
sleep efficiency 1.23±1.19 0.68±0.89 0.55±1.26 2.03 0.06 
overall sleep 
quality 
10.56±2.15 6.91±2.31 3.68±2.38 7.26 0.00** 
control 
group 
sleep duration 1.09±0.92 1.09±0.92 0.00±0.00 0.00 1.00 
sleep efficiency 0.55±0.67 0.73±0.77 -0.18±0.90 -0.94 0.36 
overall sleep 
quality 
8.64±2.22 7.95±2.40 0.68±1.52 2.10 0.05* 
P<0.05*; p<0.01**; 3rd post-test indicates on 6 weeks after intervention. 
 
Discussion 
Discussion and Analysis of Demographic Information 
The average age of all subjects in the study was 52.2 years, 38.6% and 
61.4% for men and women, respectively. Based on the clinical research 
results, outpatients with type 2 diabetes associated sleep problems (PSQI≧6), 
the mean age was 69.9 years, 24.4% for men and 75.6% for women (Lopes et 
al, 2005). Our study shows that the subjects’ ages are different from those; 
however the ratio of male to female is similar. The reason that our study 
reflected a younger age group may be that, the study subjects were limited to 
18-65 years of age, thus the results are of a younger age group than that of 
other studies.  
Our study of nocturia patients accounted for 59.1%. According to 
Pearson's product correlation coefficient, results showed that nocturia was 
associated with sleep disturbance of PSQI (p=0.05), and it was the only factor 
positively related to sleep disturbance, however, no correlation with daytime 
dysfunction. There was a significant association between nocturia and daytime 
dysfunction in male patients or patients under 65 years of age (Shao, Wu, Hsu, 
Change, Wange, & Tam, 2016). Nocturia is one of the causes of sleep 
disorders. However, there is currently no definitive assessment of the most 
relevant treatment for nocturia (Ancoli-Israel, Bliwise, & Nørgaard, 2011). 
Nocturia and sleep quality, sleep disturbance, and daytime dysfunction still 
rely on in-depth discussion and research to better understand the problems 
between nocturia and sleep, in order to tackle the problem thereof. 
Studies have shown that the mechanism of association between sleep 
quality and Body Mass Index (BMI) is unclear (Hung et al., 2013). Studies 
have also shown that people with BMI ≥ 25, there were 51% scored a PSQI > 
5, sleep quality is poor, and sleep disorders are associated with overweight 
after age and gender control (Vargas, Flores, and Robles, 2014). However, 
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based on our study, there were 69.9% patients with a BMI >25, the statistics 
based on Pearson's product correlation coefficient shows that there is no 
correlation between BMI and any domain of PSQI. 
 
Diabetes with RLS and sleep quality 
Lin, Tsai, & Yeh (2016) stated that the average sleep time of quality 
sleep in diabetic patients is 7.2 hours, of which 35.1% of participants have a 
sleep duration of less than 7 hours. According to Sirdhar (2003), an average 
sleep time of 7.2 hours; all participants indicated that they wished to sleep an 
additional 1.8 hours per night. From our study, the average sleep time of the 
study subjects was 5.75 hours, which was slightly less than that of other 
studies. The reason may be that, the study population is not just simply based 
on diabetes alone, and RLS may be the reason for the patient to be sleep 
deprived. Diabetes with RLS sleep quality is worse than that of patients with 
diabetes alone, and may be the main cause of sleep disruption in these patients.   
The participants had varying degrees of poor sleep quality in our study. 
The overall sleep quality of the PSQI was 9.55, with a minimum score of 6 
and a maximum score of 15 points. A study presented an average PSQI score 
of 8.3 and 71% of patients with a score of > 5. They also presented average 
amount of self-reported sleep of diabetic patients was 6.10 hours, the mean 
difference between preferred and actual weekday sleep was 1.83 ± 2.01 hours. 
There is significant difference in actual sleep hours, representing the presence 
of sleep debt in diabetic patients (Vigg, Vigg, and Vigg, 2003). Compared 
with above study, our study scored a much higher PSQI average score, 
representing poor sleep quality. This may be due to the fact that our study 
screened diabetic patients with RLS with a PSQI > 5, and the two other 
comparative study cases included sleep status in diabetic patients, with or 
without RLS. 
In our study, according to the seven components of PSQI, the sleep 
quality of participants scored the worse in sleep latency, which means long 
time in attempting to fall asleep. It has been pointed out in the literature that 
people with diabetes are most often suffering from difficulty falling asleep 
(Malloney, Browan & Hetta, 2005; Gottlieb, Punjabi, Newman, Resnicj, 
Redline, Baldwin & Nieto, 2005). Based on the study by Skomto, Ludwig, and 
Salamon (2001), patients with Type 2 diabetes with RLS, participants who 
experienced insomnia showed that 42.9% had difficulty falling asleep. Based 
on the above findings, it is consistent with the results of our study that 
difficulty falling asleep is one of the major sleep problem in diabetic patients, 
as well as daytime dysfunction. The low quality of sleep in patients with 
diabetes with RLS is indeed worthy of attention. 
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The effect of lavender essential oil on sleep quality 
Two articles in the systematic literature show that lavender oil has 
small to medium benefits on sleep quality (Fismer, and Pilkington, 2012). For 
people with mild sleep disorders, consider inhaling essential oils (Lillehei, and 
Halcon, 2014). Our study uses 1% lavender essential oil, a natural 
aromatherapy method for insomniac diabetic patients with RLS.  According 
to the results of the PSQI, the overall sleep quality continued to improve, down 
to 3.68 points in the sixth week, and the overall sleep quality improved. A 
study, aimed at the average college students‘ intervention on lavender 
essential oil for two weeks, showed even better sleep quality, and stated that 
waking up felt more refreshing than ever before (Lillehei, Halco ́ n, Savik, 
And Reis, 2015). The sleep quality using PSQI was measured, and the overall 
sleep quality improved by 2.5 points. It can be seen that aromatherapy is a 
relatively simple intervention that can be promoted for improving the sleep 
quality of patients. 
Sleep latency is the major sleep problem of patients in the experimental 
or control group in this study. The sleep latency was the earliest configuration 
of the PSQI after the intervention of 1% lavender essential oil in the 
experimental group, and continued until the sixth week. It may come from the 
use of lavender essential oils for calming, for promoting sleep, quick sleep, 
and calmness (Cauffield, 2001). Many human studies support their 
effectiveness in different neurological and psychological disorders, has 
indeed, shown a psychological impact (Koulivand, Ghadiri, and Gorji, 2013). 
The subjective sleep quality of our study is based on personal subjective 
feeling. After the intervention of aromatherapy, the patients in the 
experimental group can feel the improvement of sleep quality, and also the 
effect of aromatherapy on psychology.  
The results of sleep disturbance in our study, suggested pain as the 
main problem of sleep disorders due to there were 100% patients with pain. 
Lavender aroma is a mild anesthetic with analgesic and anti-inflammatory 
properties (Shenefelt, 2005). Our study suggests that improvements in sleep 
disturbance may be related to the efficacy of lavender essential oils. However, 
hence the result of this study can be used as one of the research directions in 
the future. 
After the intervention of sleep efficiency aromatherapy, there was no 
significant difference up until the sixth week. The reason may be that sleep 
efficiency may not be a problem in patients with diabetes and RLS, and it is 
known from the results of the above-mentioned sleep latency that the role of 
aromatherapy lavender essential oil is most beneficial for guiding sleep. There 
has been no research to explore the mental state of waking up during sleep 
when using aromatherapy; therefore, whether the time spent awake in bed is 
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related to aromatherapy, this issue deserves further investigation in future 
research. 
 
The effect of lavender essential oil on blood glucose 
Aromatic essential oils improve blood glucose tolerance (Jones, and 
Kassity, 2001); Lavandula stoechas essential oils significantly prevent against 
increase in blood glucose and decrease antioxidant enzyme activities induced 
by aloxan treatment. Subacute essential oil treatment induces a decrease in 
lipid peroxidation and an increase in antioxidant enzyme activity (Sebai, 
Selmi, Rtibi, Souli, Gharbi & Sakly, 2013). In our study, 1% of lavender 
essential oil improved blood glucose levels in the second week after 
intervention, and continued until the fourth week, showing the benefits of 
lavender essential oil on blood sugar in the beginning stage. In the late stage, 
the blood sugar level maintained the same level as the fourth week but did not 
have significant on sixth week. However, we suggest that should go further 
into further explore.  
 
Conclusion 
The purpose of this study was to investigate the effects of 
aromatherapy on the improvement of sleep quality and their effects on 
physiological blood glucose. The important result of integration is poor sleep 
quality in patients of diabetic with RLS, including moderately unsatisfactory 
subjective sleep quality, longer sleep latency, shorter sleep hours, moderate 
sleep disturbance, and moderate daytime dysfunction. In the experimental 
group, patients of diabetes with RLS improved their sleep latency in the 
second week after the intervention of aromatherapy, and continued to improve 
up until the sixth week; fourth week showed an improvement on subjective 
sleep quality and sleep disturbance. In the aromatherapy experimental group, 
patients of diabetes with RLS shows decrease in their blood glucose levels in 
the second week. 
 
Application and Suggestions 
From our study, sleep problems in diabetic patient with RLS is a 
common occurrence, mainly caused by difficulty falling asleep. However, at 
present, sleep problems for diabetic patients with RLS is mostly treated with 
sleeping pills. This problem deserves the attention of nursing staff, the 
development and provision of safe, non-invasive methods to promote and 
provide improvement measures, in order to improve the quality of nursing 
care. This study demonstrates that the intervention of aromatherapy can 
immediately and continuously improve the subjective sleep quality, sleep 
latency, and sleep disturbance in patients of diabetes with RLS in the 
experimental group; improvement on actual sleep hours and overall sleep 
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quality of the experimental group at night. The results of this study can be 
applied to clinical nursing practice. It is recommended that clinical nurses can 
establish the care norms and basis for aromatherapy for diabetic patients, in 
order to further develop a comprehensive care model for diabetic patients. 
 
Limitations 
This study only accepted cases in regional teaching hospitals in north 
of Taiwan. In the future, research can be carried out in hospitals in different 
regions, therefore, increasing the number of patients from different ethnic 
groups. The study of sleep quality in this study focused on measurement of 
subjective sleep perception and state of sleep, but not for objective 
physiological indicators. Future research should incorporate more objective 
measurements in order to match objective instrument or physiological 
response measurements, for more scientific and more detailed verification.  
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